In the past week, NUWE stock has gone up by 11.50%, with a monthly decline of -36.68% and a quarterly plunge of -83.37%. The volatility ratio for the week is 17.90%, and the volatility levels for the last 30 days are 13.21% for Nuwellis Inc The simple moving average for the past 20 days is -7.00% for NUWE’s stock, with a -88.57% simple moving average for the past 200 days.
Is It Worth Investing in Nuwellis Inc (NASDAQ: NUWE) Right Now?
The 36-month beta value for NUWE is at 0.41. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for NUWE is 1.12M, and currently, shorts hold a 9.48% of that float. The average trading volume for NUWE on September 19, 2024 was 470.35K shares.
NUWE) stock’s latest price update
Nuwellis Inc (NASDAQ: NUWE)’s stock price has dropped by -11.89 in relation to previous closing price of 1.43. Nevertheless, the company has seen a gain of 11.50% in its stock price over the last five trading days. globenewswire.com reported 2024-08-23 that MINNEAPOLIS, Aug. 23, 2024 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid overload, today announced that it has entered into a definitive securities purchase agreement with certain institutional investors for the purchase and sale of 496,901 shares of the Company’s common stock at a price of $1.8450 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules.
Analysts’ Opinion of NUWE
Many brokerage firms have already submitted their reports for NUWE stocks, with ROTH MKM repeating the rating for NUWE by listing it as a “Buy.” The predicted price for NUWE in the upcoming period, according to ROTH MKM is $17 based on the research report published on July 29, 2024 of the current year 2024.
NUWE Trading at -47.26% from the 50-Day Moving Average
After a stumble in the market that brought NUWE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -97.86% of loss for the given period.
Volatility was left at 13.21%, however, over the last 30 days, the volatility rate increased by 17.90%, as shares sank -34.72% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -66.93% lower at present.
During the last 5 trading sessions, NUWE rose by +11.50%, which changed the moving average for the period of 200-days by -94.54% in comparison to the 20-day moving average, which settled at $1.3213. In addition, Nuwellis Inc saw -93.80% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for NUWE
Current profitability levels for the company are sitting at:
- -1.53 for the present operating margin
- 0.6 for the gross margin
The net margin for Nuwellis Inc stands at -2.26. The total capital return value is set at -6.36. Equity return is now at value -987.45, with -192.57 for asset returns.
Based on Nuwellis Inc (NUWE), the company’s capital structure generated -0.11 points at debt to capital in total, while cash flow to debt ratio is standing at -18.65. The debt to equity ratio resting at -0.1. The interest coverage ratio of the stock is -1.52.
Currently, EBITDA for the company is -17.27 million with net debt to EBITDA at 0.03. When we switch over and look at the enterprise to sales, we see a ratio of 0.22. The receivables turnover for the company is 6.98for trailing twelve months and the total asset turnover is 1.46. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.20.
Conclusion
In conclusion, Nuwellis Inc (NUWE) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
